Nivolumab in recurrent/metastatic head and neck cancers.
about
Nivolumab in recurrent/metastatic head and neck cancers.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Nivolumab in recurrent/metastatic head and neck cancers.
@en
Nivolumab in recurrent/metastatic head and neck cancers.
@nl
type
label
Nivolumab in recurrent/metastatic head and neck cancers.
@en
Nivolumab in recurrent/metastatic head and neck cancers.
@nl
prefLabel
Nivolumab in recurrent/metastatic head and neck cancers.
@en
Nivolumab in recurrent/metastatic head and neck cancers.
@nl
P2093
P2860
P356
P1433
P1476
Nivolumab in recurrent/metastatic head and neck cancers.
@en
P2093
Andy Karabajakian
Jérôme Fayette
Thibaut Reverdy
P2860
P356
10.2217/FON-2017-0440
P407
P577
2017-11-13T00:00:00Z